BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15370067)

  • 1. Suppression of oxidative stress in the endothelium and vascular wall.
    Jiang F; Drummond GR; Dusting GJ
    Endothelium; 2004; 11(2):79-88. PubMed ID: 15370067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms for suppressing NADPH oxidase in the vascular wall.
    Dusting GJ; Selemidis S; Jiang F
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():97-103. PubMed ID: 15962105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
    Montezano AC; Touyz RM
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
    Förstermann U; Münzel T
    Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(P)H oxidase and endothelial dysfunction.
    Muller G; Morawietz H
    Horm Metab Res; 2009 Feb; 41(2):152-8. PubMed ID: 18816427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis.
    Laufs U; Wassmann S; Czech T; Münzel T; Eisenhauer M; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):809-14. PubMed ID: 15692095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
    Förstermann U
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells.
    Tumur Z; Niwa T
    Am J Nephrol; 2009; 29(6):551-7. PubMed ID: 19129694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gender and sex hormones on vascular oxidative stress.
    Miller AA; De Silva TM; Jackman KA; Sobey CG
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1037-43. PubMed ID: 17714091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology.
    Bengtsson SH; Gulluyan LM; Dusting GJ; Drummond GR
    Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):849-54. PubMed ID: 14678249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel isoforms of NADPH-oxidase in cerebral vascular control.
    Miller AA; Drummond GR; Sobey CG
    Pharmacol Ther; 2006 Sep; 111(3):928-48. PubMed ID: 16616784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.